Magsoothium Cbd Body Lavender Cream
NDC Package 83262-003-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Magsoothium Cbd Body Lavender (menthol) cream is stop use and ask a doctor if Condition worsens or symptoms persist for more than 7 days or clear up and recur Redness is present or irritation. This formulation utilizes a cream delivery system. Marketed by Ubu/elements, Inc., this product is identified by NDC 83262-003 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
83262-003-01
Package Description
112 mL in 1 JAR
Product Code
83262-003
11-Digit Billing Format
83262000301

Clinical Specifications

Proprietary Name
Magsoothium Cbd Body Lavender
Non-Proprietary Name
Menthol
Substance Name
Menthol
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
MENTHOL 5 g/100mL
Usage Information
Stop use and ask a doctor if Condition worsens or symptoms persist for more than 7 days or clear up and recur Redness is present or irritation

Regulatory & Marketing

Labeler Name
Ubu/elements, Inc.
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-21-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83262-003-01 identifies a specific commercial package of 112 ml in 1 jar of Magsoothium Cbd Body Lavender, a human over the counter drug labeled by Ubu/elements, Inc.. This cream is formulated for topical use and contains menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ubu/elements, Inc. on April 21, 2023. The current certification is valid through December 31, 2026.

How is this Ubu/elements, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83262000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83262-003-01
11-Digit CMS (5-4-2)
83262-0003-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.